Prevalence and outcomes of atrial fibrillation in a European healthcare area gained through the processing of a health information technology system.


Journal

Revista portuguesa de cardiologia
ISSN: 2174-2049
Titre abrégé: Rev Port Cardiol (Engl Ed)
Pays: Spain
ID NLM: 101770878

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 14 09 2017
revised: 04 03 2018
accepted: 03 06 2018
pubmed: 20 1 2019
medline: 18 12 2019
entrez: 20 1 2019
Statut: ppublish

Résumé

Today's healthcare policies rely heavily on data that has been gathered from multiple small studies in intrinsically varied populations. We sought to describe the prevalence, comorbidities and outcomes of atrial fibrillation (AF) in the population of a specific region where all healthcare centers have implemented a common information technology (IT) structure. The total number of inhabitants was obtained from the healthcare area's IT system. Information pertaining to AF was derived from various datasets in the data warehouse of the Galician regional health service. In the healthcare area of Santiago de Compostela (n=383000), the diagnosis of AF was coded in 7990 (2.08%) individuals in 2013. Mean age was 76.83±10.5 years, mean CHA In this study, we report for the first time the true prevalence of diagnosed AF and its clinical characteristics, treatment and prognosis in a Spanish healthcare area, based on the systematic integration of data available from a universally adopted health IT system within the region.

Identifiants

pubmed: 30658865
pii: S0870-2551(17)30688-1
doi: 10.1016/j.repc.2018.06.008
pii:
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Multicenter Study

Langues

eng por

Sous-ensembles de citation

IM

Pagination

21-29

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Moisés Rodríguez-Mañero (M)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain. Electronic address: moirmanero@gmail.com.

Estrella López-Pardo (E)

Gerencia de Gestión Integrada, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain.

Alberto Cordero-Fort (A)

Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain; Hospital Universitario San Juan de Alicante, Alicante, Spain.

Jose Luis Martínez-Sande (JL)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain.

Carlos Peña-Gil (C)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain.

José Novo Platas (JN)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain.

Javier García-Seara (J)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain.

Pilar Mazón (P)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain.

Alfonso Varela-Román (A)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain.

Jose María García-Acuña (JM)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain.

José Ramón González-Juanatey (JR)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH